151 related articles for article (PubMed ID: 8062253)
1. Prevention of breast cancer in the rat with 9-cis-retinoic acid as a single agent and in combination with tamoxifen.
Anzano MA; Byers SW; Smith JM; Peer CW; Mullen LT; Brown CC; Roberts AB; Sporn MB
Cancer Res; 1994 Sep; 54(17):4614-7. PubMed ID: 8062253
[TBL] [Abstract][Full Text] [Related]
2. 1 alpha,25-Dihydroxy-16-ene-23-yne-26,27-hexafluorocholecalciferol (Ro24-5531), a new deltanoid (vitamin D analogue) for prevention of breast cancer in the rat.
Anzano MA; Smith JM; Uskoković MR; Peer CW; Mullen LT; Letterio JJ; Welsh MC; Shrader MW; Logsdon DL; Driver CL
Cancer Res; 1994 Apr; 54(7):1653-6. PubMed ID: 8137276
[TBL] [Abstract][Full Text] [Related]
3. Tumor prevention by 9-cis-retinoic acid in the N-nitroso-N-methylurea model of mammary carcinogenesis is potentiated by the pineal hormone melatonin.
Nowfar S; Teplitzky SR; Melancon K; Kiefer TL; Cheng Q; Dwived PD; Bischoff ED; Moro K; Anderson MB; Dai J; Lai L; Yuan L; Hill SM
Breast Cancer Res Treat; 2002 Mar; 72(1):33-43. PubMed ID: 12004806
[TBL] [Abstract][Full Text] [Related]
4. Chemoprevention of mammary carcinoma by LGD1069 (Targretin): an RXR-selective ligand.
Gottardis MM; Bischoff ED; Shirley MA; Wagoner MA; Lamph WW; Heyman RA
Cancer Res; 1996 Dec; 56(24):5566-70. PubMed ID: 8971154
[TBL] [Abstract][Full Text] [Related]
5. Chemoprevention of MNU-induced mammary tumors in the mature rat by 4-HPR and tamoxifen.
Moon RC; Kelloff GJ; Detrisac CJ; Steele VE; Thomas CF; Sigman CC
Anticancer Res; 1992; 12(4):1147-53. PubMed ID: 1386970
[TBL] [Abstract][Full Text] [Related]
6. Effects of tamoxifen and melatonin on mammary gland cancer induced by N-methyl-N-nitrosourea and by 7,12-dimethylbenz(a)anthracene, respectively, in female Sprague-Dawley rats.
Kubatka P; Bojková B; M ciková-Kalická K; Mníchová-Chamilová M; Adámeková E; Ahlers I; Ahlersová E; Cermáková M
Folia Biol (Praha); 2001; 47(1):5-10. PubMed ID: 11232869
[TBL] [Abstract][Full Text] [Related]
7. Beyond tamoxifen: the retinoid X receptor-selective ligand LGD1069 (TARGRETIN) causes complete regression of mammary carcinoma.
Bischoff ED; Gottardis MM; Moon TE; Heyman RA; Lamph WW
Cancer Res; 1998 Feb; 58(3):479-84. PubMed ID: 9458093
[TBL] [Abstract][Full Text] [Related]
8. LAS, a novel selective estrogen receptor modulator with chemopreventive and therapeutic activity in the N-nitroso-N-methylurea-induced rat mammary tumor model.
Cohen LA; Pittman B; Wang CX; Aliaga C; Yu L; Moyer JD
Cancer Res; 2001 Dec; 61(24):8683-8. PubMed ID: 11751385
[TBL] [Abstract][Full Text] [Related]
9. Suppression of mammary gland carcinogenesis by post-initiation treatment of rats with tamoxifen or indole-3-carbinol or their combination.
Malejka-Giganti D; Parkin DR; Bennett KK; Lu Y; Decker RW; Niehans GA; Bliss RL
Eur J Cancer Prev; 2007 Apr; 16(2):130-41. PubMed ID: 17297389
[TBL] [Abstract][Full Text] [Related]
10. Effect of tamoxifen on preneoplastic cell proliferation in N-nitroso-N-methylurea-induced mammary carcinogenesis.
Osborne MP; Ruperto JF; Crowe JP; Rosen PP; Telang NT
Cancer Res; 1992 Mar; 52(6):1477-80. PubMed ID: 1540955
[TBL] [Abstract][Full Text] [Related]
11. A new ligand for the peroxisome proliferator-activated receptor-gamma (PPAR-gamma), GW7845, inhibits rat mammary carcinogenesis.
Suh N; Wang Y; Williams CR; Risingsong R; Gilmer T; Willson TM; Sporn MB
Cancer Res; 1999 Nov; 59(22):5671-3. PubMed ID: 10582681
[TBL] [Abstract][Full Text] [Related]
12. Antitumor action of physiological estradiol on tamoxifen-stimulated breast tumors grown in athymic mice.
Yao K; Lee ES; Bentrem DJ; England G; Schafer JI; O'Regan RM; Jordan VC
Clin Cancer Res; 2000 May; 6(5):2028-36. PubMed ID: 10815929
[TBL] [Abstract][Full Text] [Related]
13. The impact of fish oil on the chemopreventive efficacy of tamoxifen against development of N-methyl-N-nitrosourea-induced rat mammary carcinogenesis.
Manni A; Xu H; Washington S; Aliaga C; Cooper T; Richie JP; Bruggeman R; Prokopczyk B; Calcagnotto A; Trushin N; Mauger D; Verderame MF; El-Bayoumy K
Cancer Prev Res (Phila); 2010 Mar; 3(3):322-30. PubMed ID: 20179301
[TBL] [Abstract][Full Text] [Related]
14. Effect of rosiglitazone on N-nitroso-N-methylurea-induced mammary tumors in rat.
Núñez M; Martín G; Cocca C; Mohamad N; Gutiérrez A; Cricco G; Medina V; Rivera E; Croci M; Crescenti E; Bergoc R
Anticancer Res; 2006; 26(3A):2113-22. PubMed ID: 16827153
[TBL] [Abstract][Full Text] [Related]
15. Regression of NMU-induced mammary tumors with the combination of melatonin and 9-cis-retinoic acid.
Melancon K; Cheng Q; Kiefer TL; Dai J; Lai L; Dong C; Yuan L; Collins A; Thiyagarajah A; Long S; Hill SM
Cancer Lett; 2005 Sep; 227(1):39-48. PubMed ID: 16051031
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of growth of established N-methyl-N-nitrosourea-induced mammary cancer in rats by retinoic acid and ovariectomy.
Lacroix A; Doskas C; Bhat PV
Cancer Res; 1990 Sep; 50(18):5731-4. PubMed ID: 2393847
[TBL] [Abstract][Full Text] [Related]
17. An antiangiogenic urokinase-derived peptide combined with tamoxifen decreases tumor growth and metastasis in a syngeneic model of breast cancer.
Guo Y; Mazar AP; Lebrun JJ; Rabbani SA
Cancer Res; 2002 Aug; 62(16):4678-84. PubMed ID: 12183425
[TBL] [Abstract][Full Text] [Related]
18. [Effect of tamoxifen plus octreotide on DMBA-induced mammary tumors in rats].
Zeng XZ; Yao ZX
Zhonghua Yi Xue Za Zhi; 2005 Jan; 85(1):28-32. PubMed ID: 15808071
[TBL] [Abstract][Full Text] [Related]
19. Sulfone metabolite of sulindac inhibits mammary carcinogenesis.
Thompson HJ; Jiang C; Lu J; Mehta RG; Piazza GA; Paranka NS; Pamukcu R; Ahnen DJ
Cancer Res; 1997 Jan; 57(2):267-71. PubMed ID: 9000566
[TBL] [Abstract][Full Text] [Related]
20. Effects of liarozole fumarate (R85246) in combination with tamoxifen on N-methyl-N-nitrosourea (MNU)-induced mammary carcinoma and uterus in the rat model.
Goss PE; Strasser-Weippl K; Qi S; Hu H
BMC Cancer; 2007 Jan; 7():26. PubMed ID: 17266767
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]